# Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

> **NCT01687751** · PHASE2 · WITHDRAWN · sponsor: **Fraser Health**

## Conditions studied

- Pain Intractable
- Delirium
- Dyspnea
- Nausea

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01687751
- **Lead sponsor:** Fraser Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study design determined to be not likely feasible
- **Last updated:** 2015-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01687751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01687751, "Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01687751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*